Qing Yi, MD, PhD

Projects

Projects per year 2016 2019 2023 2024 2029

• 2 Not started
• 6 Finished
• 10 Active

Projects per year

Search results

• Active

  Phase IB/II Study Combining All-Trans Retinoic Acid (ATRA) with Carfilzomib Based Therapy in Plasma Cell Myeloma Patients Refractory to Carfilzomib

  Pingali, S. R., Ganguly, S., Mathur, S., Shah, S. & Yi, Q.

  7/29/24 → …

  Project: Clinical Trial

• Exploring the role and potential of anti-viral drugs to sensitize cancer cells to chemotherapy

  Yi, Q.

  6/1/24 → 5/31/29

  Project: Federal Funding Agencies

• Validating Novel Biologic Mediators and Therapeutic Targets in t(4;14) Myeloma

  Yi, Q.

  4/1/24 → 4/1/27

  Project: Non Profit

• Combination Therapy Using ATRA and Carfilzomib to Treat Proteasome Inhibitor Refractory Multiple Myeloma

  Yi, Q.

  3/1/24 → 2/28/28

  Project: Non Profit

• Tumor-specific CD8+ Tc9 cells activate host CD4+ T cells to control antigen-lost tumors

  Yi, Q.

  1/1/24 → 12/31/28

  Project: Federal Funding Agencies

• Role of lipid metabolism in CD8+ T cell ferroptosis

  Yi, Q.

  9/19/23 → 8/31/28

  Project: Federal Funding Agencies

• Novel mechanism of induction of tumor pyroptosis by IL-9-secreting Tc9 cells

  Yi, Q.

  8/1/23 → 7/31/28

  Project: Federal Funding Agencies

• DEVELOPING NOVEL CAR-T CELL THERAPY FOR HEMATOLOGIC MALIGNANCIES

  Yi, Q.

  7/1/23 → 6/30/26

  Project: Non Profit

• Targeting DKK1 with a DNA vaccine to prevent development of multiple myeloma

  Yi, Q.

  6/26/23 → 12/25/25

  Project: Federal Funding Agencies

• Role of tumor microenvironment-derived cholesterol in CD8+ T-cell exhaustion

  Yi, Q.

  8/1/19 → 7/31/25

  Project: Federal Funding Agencies

• Not started

  Sample and Data Collection for Hematologic disorders section, Houston Methodist Cancer Center

  Pingali, S. R., Ganguly, S., Heyne, K., Hu, C. A., Jin, M. M., Rice, L., Shah, S., Yang, J., Yi, Q. & Zieske, A. W.

  Project: Clinical Trial

• Adipose Tissue and Data Collection from Patients with and without the Diagnosis of Cancer at Houston Methodist Hospital

  Pingali, S. R., Angarita, F. A., Chang, J. C., Esnaola, N. F., Sun, K., Yang, J. & Yi, Q.

  Project: Clinical Trial

• Finished

  Role of ATRA in Overcoming Myeloma Resistance to Proteasome Inhibitors

  Yi, Q. & Wang, Q.

  8/31/21 → 2/29/24

  Project: State

• Potentiation of Multi-peptide Lung Cancer Vaccines with Immune Checkpoint Antagonist CA-170

  You, M. & Yi, Q.

  5/24/21 → 8/23/24

  Project: Federal Funding Agencies

• Targeting macrophages to sensitize myeloma to immune checkpoint blockade

  Yi, Q.

  3/1/19 → 2/28/23

  Project: Federal Funding Agencies

• Role of MIF in myeloma bone homing and drug response

  Yi, Q.

  1/1/19 → 12/31/22

  Project: Federal Funding Agencies

• CPRIT Recruitment of Established Investigator: Dr. Qing Yi

  Yi, Q.

  6/1/18 → 5/31/24

  Project: State

• A novel T-cell subset able to kill relapsed cancers

  Yi, Q.

  7/1/16 → 6/30/22

  Project: Federal Funding Agencies